Nutriband receives notice of allowance from the canadian intellectual property office for its aversa(tm) abuse deterrent transdermal technology patent

Orlando, fl / accesswire / august 1, 2022 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw) today announced that it has received a notice of allowance from the canadian intellectual property office (cipo) for its patent application, ca 2937649, entitled "abuse and misuse deterrent transdermal systems," that protects its aversa™ transdermal abuse deterrent technology. the issuance of this canadian patent in combination with patents already issued in the united states and mexico provides intellectual property protection for nutriband's aversa™ products across north america.
NTRB Ratings Summary
NTRB Quant Ranking